Thank you, Ladd. As Matt mentioned, we generated $149 million in adjusted EBITDA, $73 million in free cash flow, and we reduced our net debt by approximately $123 million. . On a consolidated basis, revenue for the third quarter totaled $574 million, a sequential decrease driven primarily by the lower fleet count. Despite this, we were able to reduce costs very quickly and limit our incrementals. In addition, we brought our CapEx down considerably, enabling us to increase our EBITDA less CapEx quarter-over-quarter. Selling, general and administrative costs were $61 million in the third quarter, down $9 million from the second quarter, largely due to lower stock compensation expense as well as lower G&A spend related to the cost reductions. The Stimulation Services segment generated revenues of $490 million in the third quarter, down from the second quarter primarily due to lower fleet count. Efficiency on the fleet was up slightly and pricing was flat compared to the prior quarter. Adjusted EBITDA for the segment was $93 million compared to $123 million in the second quarter. The Proppant Production segment generated revenues of $98 million in the third quarter, down sequentially driven by lower realized pricing in the quarter. Approximately 70% of the volumes were sold to third-party customers, similar to the last quarter. Adjusted EBITDA for the Proppant Production segment totaled approximately $52 million, down from $58 million in the second quarter. The Manufacturing segment generated revenues of $44 million in the third quarter, up approximately 41% from the second quarter. Approximately 97% of this segment was intercompany revenue for products and services provided to the Stimulation Services segment. The increase in sales represents a more normalized level of fluid end sales to Stimulation Services following the second quarter where Stimulation reduced purchases and focus on utilizing inventory on hand. Adjusted EBITDA for the Manufacturing segment was $1.6 million, down from the second quarter, primarily due to product mix. As Stimulation Services exhaust it's inventory and prepares for an increase to its fleet count, and we expect the Manufacturing revenue will continue to increase. Cash capital expenditures totaled $52.6 million in the third quarter, down 46% from the second quarter. When we reduced our fleet count, CapEx usually takes more time to be reduced. Overall, we are happy with the Q3 level of spend and the actions that we have taken. We expect to incur total CapEx of approximately $280 million to $290 million for 2023. This continues to reflect the deferral of our fleet upgrade program, which we expect will be resumed at some point in 2024 at a lower level than where we started in 2023. We will remain disciplined with our capital allocation plans, and we'll remain focused on allocating capital where it can achieve the best return on investment. For next year, we believe maintenance CapEx will run approximately $3.5 million per fleet per year for the Stimulation Services segment and $2 million to $3 million per mine per year for the Proppant Production segment. As we solidify our calendar for next year, we will be defining our growth initiatives, and we'll have more to share as we develop our comprehensive CapEx plan. Operating cash flow was $123.6 million during the quarter. Working capital was reduced by approximately $27 million, while we continue to manage our receivables and payables. In addition, we remain focused on utilizing our inventory on hand, and we expect to see continued reductions for the remainder of the year, particularly as we prepare to deploy fleets. Total cash and cash equivalents as of the end of the third quarter was $25.1 million, including $4.5 million attributable to FloTek. Total liquidity at quarter end was approximately $137 million, consisting of a combination of $20.6 million in cash, excluding FloTek, and $116 million of availability under ProFrac's asset-based credit facility. Borrowings under the ABL ended the quarter at $136 million after the application of the preferred equity proceeds. At the end of the third quarter, we had approximately $1.1 billion of debt outstanding. Our primary focus in the near term remains on generating free cash flow for delevering the balance sheet and refinancing our existing debt. We again demonstrated our flexibility in the third quarter as we produced free cash flow of $73 million, which we used to pay down approximately $112 million of outstanding debt. In connection with our strategic review, we also announced that entities affiliated with our largest shareholder, the Wilks Brothers, invested $50 million in perpetual convertible preferred equity securities issued by the company which demonstrates the Wilks confidence in ProFrac. Regarding our overall capital structure, we are looking at a fleet count, pricing level and CapEx plan that will generate a meaningful amount of free cash flow to be used for debt reduction. We believe these debt reductions, combined with the improved results that we expect next year will bring our overall leverage ratio back below our target of 1x adjusted EBITDA. In addition, the steps we've taken on Alpine should make this segment a high utilization, low-cost sand operation that will also generate meaningful free cash flow. When taken together, we believe we will see 2024 EBITDA grow meaningfully higher than what was achieved in 2023. That concludes our formal remarks. Operator, please open the line for questions.